These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 27567850)

  • 1. The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer's Disease Amyloid-β Peptide.
    Selivanova OM; Surin AK; Marchenkov VV; Dzhus UF; Grigorashvili EI; Suvorina MY; Glyakina AV; Dovidchenko NV; Galzitskaya OV
    J Alzheimers Dis; 2016 Sep; 54(2):821-30. PubMed ID: 27567850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Mechanism of Amyloid Fibril Formation.
    Galzitskaya O
    Curr Protein Pept Sci; 2019; 20(6):630-640. PubMed ID: 30686252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
    Poduslo JF; Howell KG
    J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions.
    Gu L; Guo Z
    Biochem Biophys Res Commun; 2021 Jan; 534():292-296. PubMed ID: 33272573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One of the possible mechanisms of amyloid fibrils formation based on the sizes of primary and secondary folding nuclei of Aβ40 and Aβ42.
    Dovidchenko NV; Glyakina AV; Selivanova OM; Grigorashvili EI; Suvorina MY; Dzhus UF; Mikhailina AO; Shiliaev NG; Marchenkov VV; Surin AK; Galzitskaya OV
    J Struct Biol; 2016 Jun; 194(3):404-14. PubMed ID: 27016282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
    Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
    Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of Polymorphism of Amyloid-β42 Peptide from Different Suppliers.
    Suvorina MY; Selivanova OM; Grigorashvili EI; Nikulin AD; Marchenkov VV; Surin AK; Galzitskaya OV
    J Alzheimers Dis; 2015; 47(3):583-93. PubMed ID: 26401694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structures of the E22Δ mutant-type amyloid-β alloforms and the impact of E22Δ mutation on the structures of the wild-type amyloid-β alloforms.
    Coskuner O; Wise-Scira O; Perry G; Kitahara T
    ACS Chem Neurosci; 2013 Feb; 4(2):310-20. PubMed ID: 23421682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca(2+), within the physiological concentrations, selectively accelerates Abeta42 fibril formation and not Abeta40 in vitro.
    Ahmad A; Muzaffar M; Ingram VM
    Biochim Biophys Acta; 2009 Oct; 1794(10):1537-48. PubMed ID: 19595795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synchrotron-based hydroxyl radical footprinting analysis of amyloid fibrils and prefibrillar intermediates with residue-specific resolution.
    Klinger AL; Kiselar J; Ilchenko S; Komatsu H; Chance MR; Axelsen PH
    Biochemistry; 2014 Dec; 53(49):7724-34. PubMed ID: 25382225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aβ40 and Aβ42 amyloid fibrils exhibit distinct molecular recycling properties.
    Sánchez L; Madurga S; Pukala T; Vilaseca M; López-Iglesias C; Robinson CV; Giralt E; Carulla N
    J Am Chem Soc; 2011 May; 133(17):6505-8. PubMed ID: 21486030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To Be Fibrils or To Be Nanofilms? Oligomers Are Building Blocks for Fibril and Nanofilm Formation of Fragments of Aβ Peptide.
    Selivanova OM; Surin AK; Ryzhykau YL; Glyakina AV; Suvorina MY; Kuklin AI; Rogachevsky VV; Galzitskaya OV
    Langmuir; 2018 Feb; 34(6):2332-2343. PubMed ID: 29338255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous in vitro formation of supramolecular beta-amyloid structures, "betaamy balls", by beta-amyloid 1-40 peptide.
    Westlind-Danielsson A; Arnerup G
    Biochemistry; 2001 Dec; 40(49):14736-43. PubMed ID: 11732892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E22G Aβ40 fibril structure and kinetics illuminate how Aβ40 rather than Aβ42 triggers familial Alzheimer's.
    Tehrani MJ; Matsuda I; Yamagata A; Kodama Y; Matsunaga T; Sato M; Toyooka K; McElheny D; Kobayashi N; Shirouzu M; Ishii Y
    Nat Commun; 2024 Aug; 15(1):7045. PubMed ID: 39147751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key residues for the oligomerization of Aβ42 protein in Alzheimer's disease.
    Ngo S; Guo Z
    Biochem Biophys Res Commun; 2011 Oct; 414(3):512-6. PubMed ID: 21986527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of the amyloid β40 dimer model with a linker at position 30 adjacent to the intermolecular β-sheet region.
    Murakami K; Suzuki T; Hanaki M; Monobe Y; Akagi K; Irie K
    Biochem Biophys Res Commun; 2015 Oct; 466(3):463-7. PubMed ID: 26367176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural origin of polymorphism of Alzheimer's amyloid β-fibrils.
    Agopian A; Guo Z
    Biochem J; 2012 Oct; 447(1):43-50. PubMed ID: 22823461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation at Ser
    Hu ZW; Ma MR; Chen YX; Zhao YF; Qiang W; Li YM
    J Biol Chem; 2017 Feb; 292(7):2611-2623. PubMed ID: 28031462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
    Wang L; Eom K; Kwon T
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.